Bioinformatics and Biology Insights

Scope & Guideline

Advancing the intersection of biology and computation.

Introduction

Welcome to your portal for understanding Bioinformatics and Biology Insights, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1177-9322
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2009 to 2024
AbbreviationBIOINFORM BIOL INSIG / Bioinform. Biol. Insights
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal "Bioinformatics and Biology Insights" primarily focuses on the intersection of bioinformatics and biological research, leveraging computational tools and methodologies to advance understanding in various biological systems and diseases. Its core areas include:
  1. Bioinformatics and Computational Biology:
    Utilization of computational methods to analyze biological data, including genomic, transcriptomic, and proteomic datasets, to derive insights into biological processes and disease mechanisms.
  2. Disease Mechanism and Therapeutics:
    Investigation of the molecular underpinnings of diseases, including cancer, infectious diseases, and autoimmune disorders, often involving identification of biomarkers and therapeutic targets.
  3. Systems Biology:
    Integration of biological data from multiple sources to understand complex interactions within biological systems and to model biological processes.
  4. Machine Learning and AI Applications:
    Application of machine learning techniques to predict biological outcomes, identify drug candidates, and enhance the analysis of biological data.
  5. Omics Research:
    Focus on various omics studies (genomics, proteomics, metabolomics) to explore the molecular basis of health and disease, and to identify potential therapeutic strategies.
  6. Pharmacoinformatics and Drug Discovery:
    Exploration of computational approaches for drug discovery, including molecular docking, virtual screening, and the design of novel therapeutic compounds.
  7. Epidemiological and Environmental Studies:
    Research that incorporates bioinformatics to study the epidemiology of infectious diseases and the impact of environmental factors on health.
  8. Bioinformatics Tools Development:
    Creation and enhancement of bioinformatics tools and databases to facilitate the analysis of biological data and improve research methodologies.
Recent publications in "Bioinformatics and Biology Insights" highlight several trending and emerging themes that reflect the evolving landscape of bioinformatics research. The following areas are gaining traction and are likely to shape future research directions:
  1. Integrative Multi-Omics Approaches:
    There is a growing trend towards integrating various omics data (genomics, transcriptomics, proteomics) to better understand complex biological systems and diseases.
  2. Artificial Intelligence in Drug Discovery:
    The application of AI and machine learning techniques for drug discovery and development is rapidly increasing, with numerous studies focusing on predictive modeling and virtual screening.
  3. COVID-19 Related Research:
    Given the ongoing impact of the COVID-19 pandemic, there is a significant increase in research related to SARS-CoV-2, including studies on variants, vaccine development, and therapeutic targets.
  4. Personalized Medicine and Biomarker Discovery:
    Research aimed at identifying biomarkers for personalized treatment approaches is on the rise, with a focus on tailoring therapies based on individual genetic profiles.
  5. Bioinformatics for Environmental and Epidemiological Studies:
    An emerging focus on utilizing bioinformatics tools to study the impact of environmental factors on health and to investigate epidemiological trends in infectious diseases.
  6. Phytochemical and Natural Product Studies:
    There is an increasing interest in the bioinformatics analysis of natural compounds for therapeutic applications, particularly for their potential antiviral and anticancer properties.
  7. Network Pharmacology:
    The application of network pharmacology to explore the interactions of drugs within biological networks is gaining importance as a means to understand multi-target drug effects.

Declining or Waning

While "Bioinformatics and Biology Insights" has a broad and dynamic focus, certain themes appear to be declining in prominence over recent publications. The following areas have seen a reduction in publications or interest:
  1. Traditional Experimental Approaches:
    There is a noticeable decline in studies relying solely on traditional laboratory techniques without the integration of computational methods, as the field increasingly values data-driven approaches.
  2. Basic Descriptive Studies:
    Research that merely describes biological phenomena without employing deeper computational analysis or hypothesis testing is becoming less common, as the field shifts towards more analytical studies.
  3. Standalone Bioinformatics Methods:
    Papers focusing exclusively on bioinformatics methods without application to biological questions or integration with experimental data are appearing less frequently.
  4. Single-Omics Studies:
    The focus is shifting away from single-omics studies, such as only genomics or proteomics, as integrative multi-omics approaches gain traction for a more comprehensive understanding of biological systems.

Similar Journals

Network Modeling and Analysis in Health Informatics and Bioinformatics

Advancing methodologies for better health outcomes.
Publisher: SPRINGER WIENISSN: 2192-6662Frequency: 1 issue/year

Network Modeling and Analysis in Health Informatics and Bioinformatics, published by SPRINGER WIEN, stands as a vital resource in the interdisciplinary domains of health informatics and bioinformatics. With an ISSN of 2192-6662 and E-ISSN of 2192-6670, this journal aims to facilitate the dissemination of innovative research that intersects network modeling, data analysis, and health applications. The journal competes at a Q3 quartile level across multiple categories including Biomedical Engineering and Health Informatics, showcasing its growing influence within the academic community. As of 2023, it holds impressive Scopus rankings, including a 20th position in Urology, illustrating its significance in the field. Although not an open access publication, the journal is dedicated to providing cutting-edge insights from 2012 to 2024 and is poised to attract researchers, professionals, and students striving to push the boundaries of knowledge in health informatics and bioinformatics. This journal is not just a platform for sharing scholarly articles; it is a catalyst for advancing methodologies that enhance patient care and medical research.

npj Systems Biology and Applications

Transforming Drug Discovery through Systems Insights
Publisher: NATURE PORTFOLIOISSN: Frequency: 1 issue/year

npj Systems Biology and Applications, published by NATURE PORTFOLIO, is a premier open-access journal that has been at the forefront of the field since its inception in 2015. With a commendable focus on the interdisciplinary integration of applied mathematics, biochemistry, computer science, and drug discovery, the journal currently enjoys a Q1 ranking across multiple categories, showcasing its significant impact within the scientific community. In 2023, it ranked 70 out of 635 in Applied Mathematics and holds a notable place in the 89th percentile, confirming its esteemed reputation among researchers. Situated in the United Kingdom, this journal not only promotes innovative research in systems biology but also serves as an essential platform for the dissemination of high-quality studies that delve into modeling, simulation, and the application of biological systems in drug discovery processes. With an open-access model, authors can reach a broad audience, enhancing collaborations and advancing knowledge across disciplines, making it an indispensable resource for researchers, professionals, and students alike seeking to contribute to the evolving landscape of systems biology.

Quantitative Biology

Transforming Biological Research with Mathematical Precision
Publisher: WILEYISSN: 2095-4689Frequency: 4 issues/year

Quantitative Biology is a prestigious journal published by WILEY, focusing on the interdisciplinary study of quantitative approaches in the biological sciences. With an ISSN of 2095-4689 and an E-ISSN of 2095-4697, this journal has established itself as a critical platform for researchers exploring complex biological systems through mathematical and computational methodologies. Operating out of China, Quantitative Biology significantly contributes to its field, holding a Q2 ranking in various categories, including Applied Mathematics and Biochemistry, Genetics and Molecular Biology, according to the latest Scopus rankings. These rankings reflect the journal's commitment to publishing high-quality research that employs advanced modeling and simulation techniques. The journal's impact is evident with its position in the 84th percentile for Applied Mathematics, indicating its relevance and growth in a competitive academic landscape. Although it does not currently operate under an Open Access model, the journal is pivotal for professionals and students alike, aiming to bridge the gap between mathematical theories and biological applications. Researchers are encouraged to submit their innovative findings and engage with the vibrant community dedicated to advancing the quantitative understanding of biological phenomena.

COMPUTATIONAL BIOLOGY AND CHEMISTRY

Unraveling Complex Biological Mysteries with Computational Precision
Publisher: ELSEVIER SCI LTDISSN: 1476-9271Frequency: 6 issues/year

COMPUTATIONAL BIOLOGY AND CHEMISTRY is a distinguished academic journal published by Elsevier Science Ltd, focusing on the dynamic intersection of computational biology, biochemistry, and chemistry. With an ISSN of 1476-9271 and an E-ISSN of 1476-928X, this journal is committed to disseminating high-quality research that employs computational techniques to solve complex biological and chemical problems. As of 2023, the journal holds a substantial impact factor reflecting its significance and rigorous peer-review process, categorized in the Q2 quartile for both Computational Mathematics and Organic Chemistry, alongside Q3 classifications in Biochemistry and Structural Biology. With a continuous publication history spanning from 2003 to 2024, it serves as a critical resource for researchers, professionals, and students alike. The journal offers various open access options, ensuring that vital research findings are accessible to a global audience, further enhancing collaboration across disciplines. Engage with cutting-edge studies and contribute to the evolving landscape of computational methodologies in the life sciences through this esteemed publication.

ACS Bio & Med Chem Au

Exploring breakthroughs in pharmaceutical sciences and molecular biology.
Publisher: AMER CHEMICAL SOCISSN: Frequency: 6 issues/year

ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Pioneering research for a deeper understanding of life sciences.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0006-291XFrequency: 52 issues/year

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

COMPUTERS IN BIOLOGY AND MEDICINE

Elevating Medical Insights with Computational Excellence
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0010-4825Frequency: 16 issues/year

COMPUTERS IN BIOLOGY AND MEDICINE is a prestigious academic journal published by Pergamon-Elsevier Science Ltd, dedicated to advancing the fields of Computer Science Applications and Health Informatics. With an impressive impact factor and ranking within the Q1 quartile for both categories, this journal plays a crucial role in disseminating high-quality research findings that influence cutting-edge developments at the intersection of computing and healthcare. Covering a broad range of topics from computational biology to medical informatics, it serves as a vital resource for researchers, professionals, and students striving to harness technology for medical advancements. The journal has been publishing since 1970 and continues to evolve, incorporating the latest trends and innovations in the field, thereby ensuring that it remains a key contributor to scientific inquiry and knowledge. With accessible content and a global reach, COMPUTERS IN BIOLOGY AND MEDICINE invites submissions that elevate the understanding and application of computational methods in biological and medical contexts.

Briefings in Functional Genomics

Shaping the Future of Biochemical Research
Publisher: OXFORD UNIV PRESSISSN: 2041-2649Frequency: 6 issues/year

Briefings in Functional Genomics, published by Oxford University Press, serves as a crucial academic resource in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 2041-2649 and an E-ISSN of 2041-2657, this esteemed journal explores innovative research and developments in functional genomics, with a commitment to advancing our understanding of genetic processes and their implications in health and disease. Ranking in the Q2 quartile for both Biochemistry and Genetics, and occupying a prominent Q1 status in the domain of interdisciplinary Medicine, the journal is positioned as a leading platform for researchers seeking to disseminate their findings to a global audience. Although it does not currently offer open access options, its accessibility through institutional subscriptions and its esteemed impact factor underscore its importance in the research community. Covering converging topics from 2010 to 2024, Briefings in Functional Genomics not only keeps pace with the rapidly evolving landscape of genomics but also stimulates collaboration and dialogue among scientists and industry professionals alike, making it an indispensable tool for researchers, practitioners, and students eager to engage with cutting-edge genomic science.

BIOINFORMATICS

Advancing the Frontiers of Bioinformatics Research
Publisher: OXFORD UNIV PRESSISSN: 1367-4803Frequency: 24 issues/year

BIOINFORMATICS, published by Oxford University Press, is a leading journal in the realms of biochemistry, computational mathematics, and computer science, with a notable impact factor that underscores its significance in the field. Since its inception in 1985 and continuing through its expected convergence in 2024, the journal has maintained a prestigious reputation, proudly residing in the Q1 category across multiple disciplines, including molecular biology and statistics. With a Scopus ranking placing it within the top percentiles of its categories, BIOINFORMATICS serves as an essential platform for disseminating high-quality research that advances knowledge and innovation at the intersection of biology and computational sciences. This journal not only offers both subscription and open access options, ensuring wider availability of its cutting-edge research, but it has also become a crucial resource for researchers, professionals, and students aiming to stay at the forefront of bioinformatics and related fields. Explore the latest findings and trends that define the future of biological research through this esteemed publication, any inquiries regarding the journal can be directed to its offices located at Great Clarendon St, Oxford OX2 6DP, England.

Frontiers in Bioinformatics

Empowering Research Through Innovative Bioinformatics
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Bioinformatics is a leading academic journal dedicated to advancing the field of bioinformatics by publishing high-quality research and review articles. Published by FRONTIERS MEDIA SA, this open-access journal aims to foster innovative research, promote collaborative initiatives, and provide a platform for the dissemination of findings related to computational biology, biostatistics, and the intersection of bioinformatics with other biological disciplines. With a focus on promoting accessibility and visibility of research, Frontiers in Bioinformatics operates under a rigorous peer-review process, ensuring that all published content meets the highest academic standards. The journal has shown a commendable rank across various Scopus categories, including Mathematics, Computational Mathematics, and multiple dimensions of Biochemistry and Molecular Biology, indicating its relevance and impact within the research community. Researchers, professionals, and students will find this journal invaluable for staying abreast of the latest developments and breakthroughs in bioinformatics, enhancing their studies and professional projects.